This JAMA Network Open study examines the impact of cannabis legalization on high-risk young adults in Ontario, Canada, revealing mixed results. While frequent users reduced their cannabis use post-legalization, leading to fewer adverse consequences, those who were non-users before legalization slightly increased their use over time.
Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business – Biotech Investments
EQS-News: Heidelberg Pharma AG / Key word(s): Half Year Report Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business 13.07.2023 / 07:04